Selected research
Industry Research
Pharmaceutical Grade USP L-Glutamine Industry Research Report 2026
Market perspective
The global Pharmaceutical Grade USP L-Glutamine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pharmaceutical Grade USP L-Glutamine is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pharmaceutical Grade USP L-Glutamine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Grade USP L-Glutamine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pharmaceutical Grade USP L-Glutamine include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharmaceutical Grade USP L-Glutamine market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Pharmaceutical Grade USP L-Glutamine.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Grade USP L-Glutamine Market by Company
Kyowa Hakko
Fufeng Group
MeiHua Holdings Group
Ajinomoto
Daesang
Pharmaceutical Grade USP L-Glutamine Segment by Type
Powder
Granulated
Solution
Pharmaceutical Grade USP L-Glutamine Segment by Application
Factory
Laboratory
Pharmaceutical Grade USP L-Glutamine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade USP L-Glutamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade USP L-Glutamine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade USP L-Glutamine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharmaceutical Grade USP L-Glutamine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharmaceutical Grade USP L-Glutamine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharmaceutical Grade USP L-Glutamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Granulated
- Solution
Applications
- Factory
- Laboratory
Companies covered
- Kyowa Hakko
- Fufeng Group
- MeiHua Holdings Group
- Ajinomoto
- Daesang
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Grade USP L-Glutamine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Powder
- 2.2.3 Granulated
- 2.2.4 Solution
- 2.3 Pharmaceutical Grade USP L-Glutamine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Factory
- 2.3.3 Laboratory
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Pharmaceutical Grade USP L-Glutamine Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Pharmaceutical Grade USP L-Glutamine Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Pharmaceutical Grade USP L-Glutamine Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Pharmaceutical Grade USP L-Glutamine Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharmaceutical Grade USP L-Glutamine Production by Manufacturers (2021-2026)
- 3.2 Global Pharmaceutical Grade USP L-Glutamine Production Value by Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Grade USP L-Glutamine Average Price by Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Grade USP L-Glutamine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharmaceutical Grade USP L-Glutamine Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Pharmaceutical Grade USP L-Glutamine Manufacturers, Product Type & Application
- 3.7 Global Pharmaceutical Grade USP L-Glutamine Manufacturers Established Date
- 3.8 Global Pharmaceutical Grade USP L-Glutamine Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Kyowa Hakko
- 4.1.1 Kyowa Hakko Pharmaceutical Grade USP L-Glutamine Company Information
- 4.1.2 Kyowa Hakko Pharmaceutical Grade USP L-Glutamine Business Overview
- 4.1.3 Kyowa Hakko Pharmaceutical Grade USP L-Glutamine Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Kyowa Hakko Product Portfolio
- 4.1.5 Kyowa Hakko Recent Developments
- 4.2 Fufeng Group
- 4.2.1 Fufeng Group Pharmaceutical Grade USP L-Glutamine Company Information
- 4.2.2 Fufeng Group Pharmaceutical Grade USP L-Glutamine Business Overview
- 4.2.3 Fufeng Group Pharmaceutical Grade USP L-Glutamine Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Fufeng Group Product Portfolio
- 4.2.5 Fufeng Group Recent Developments
- 4.3 MeiHua Holdings Group
- 4.3.1 MeiHua Holdings Group Pharmaceutical Grade USP L-Glutamine Company Information
- 4.3.2 MeiHua Holdings Group Pharmaceutical Grade USP L-Glutamine Business Overview
- 4.3.3 MeiHua Holdings Group Pharmaceutical Grade USP L-Glutamine Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 MeiHua Holdings Group Product Portfolio
- 4.3.5 MeiHua Holdings Group Recent Developments
- 4.4 Ajinomoto
- 4.4.1 Ajinomoto Pharmaceutical Grade USP L-Glutamine Company Information
- 4.4.2 Ajinomoto Pharmaceutical Grade USP L-Glutamine Business Overview
- 4.4.3 Ajinomoto Pharmaceutical Grade USP L-Glutamine Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Ajinomoto Product Portfolio
- 4.4.5 Ajinomoto Recent Developments
- 4.5 Daesang
- 4.5.1 Daesang Pharmaceutical Grade USP L-Glutamine Company Information
- 4.5.2 Daesang Pharmaceutical Grade USP L-Glutamine Business Overview
- 4.5.3 Daesang Pharmaceutical Grade USP L-Glutamine Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Daesang Product Portfolio
- 4.5.5 Daesang Recent Developments
5 Global Pharmaceutical Grade USP L-Glutamine Production by Region
- 5.1 Global Pharmaceutical Grade USP L-Glutamine Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharmaceutical Grade USP L-Glutamine Production by Region: 2021-2032
- 5.2.1 Global Pharmaceutical Grade USP L-Glutamine Production by Region: 2021-2026
- 5.2.2 Global Pharmaceutical Grade USP L-Glutamine Production Forecast by Region (2027-2032)
- 5.3 Global Pharmaceutical Grade USP L-Glutamine Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Pharmaceutical Grade USP L-Glutamine Production Value by Region: 2021-2032
- 5.4.1 Global Pharmaceutical Grade USP L-Glutamine Production Value by Region: 2021-2026
- 5.4.2 Global Pharmaceutical Grade USP L-Glutamine Production Value Forecast by Region (2027-2032)
- 5.5 Global Pharmaceutical Grade USP L-Glutamine Market Price Analysis by Region (2021-2026)
- 5.6 Global Pharmaceutical Grade USP L-Glutamine Production and Value, YOY Growth
- 5.6.1 North America Pharmaceutical Grade USP L-Glutamine Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Pharmaceutical Grade USP L-Glutamine Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Pharmaceutical Grade USP L-Glutamine Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Pharmaceutical Grade USP L-Glutamine Production Value Estimates and Forecasts (2021-2032)
6 Global Pharmaceutical Grade USP L-Glutamine Consumption by Region
- 6.1 Global Pharmaceutical Grade USP L-Glutamine Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical Grade USP L-Glutamine Consumption by Region (2021-2032)
- 6.2.1 Global Pharmaceutical Grade USP L-Glutamine Consumption by Region: 2021-2026
- 6.2.2 Global Pharmaceutical Grade USP L-Glutamine Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical Grade USP L-Glutamine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pharmaceutical Grade USP L-Glutamine Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical Grade USP L-Glutamine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pharmaceutical Grade USP L-Glutamine Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pharmaceutical Grade USP L-Glutamine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pharmaceutical Grade USP L-Glutamine Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 China Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Pharmaceutical Grade USP L-Glutamine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Pharmaceutical Grade USP L-Glutamine Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Pharmaceutical Grade USP L-Glutamine Production by Type (2021-2032)
- 7.1.1 Global Pharmaceutical Grade USP L-Glutamine Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Pharmaceutical Grade USP L-Glutamine Production Market Share by Type (2021-2032)
- 7.2 Global Pharmaceutical Grade USP L-Glutamine Production Value by Type (2021-2032)
- 7.2.1 Global Pharmaceutical Grade USP L-Glutamine Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Pharmaceutical Grade USP L-Glutamine Production Value Market Share by Type (2021-2032)
- 7.3 Global Pharmaceutical Grade USP L-Glutamine Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Pharmaceutical Grade USP L-Glutamine Production by Application (2021-2032)
- 8.1.1 Global Pharmaceutical Grade USP L-Glutamine Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Pharmaceutical Grade USP L-Glutamine Production Market Share by Application (2021-2032)
- 8.2 Global Pharmaceutical Grade USP L-Glutamine Production Value by Application (2021-2032)
- 8.2.1 Global Pharmaceutical Grade USP L-Glutamine Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Pharmaceutical Grade USP L-Glutamine Production Value Market Share by Application (2021-2032)
- 8.3 Global Pharmaceutical Grade USP L-Glutamine Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Pharmaceutical Grade USP L-Glutamine Value Chain Analysis
- 9.1.1 Pharmaceutical Grade USP L-Glutamine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Pharmaceutical Grade USP L-Glutamine Production Mode & Process
- 9.2 Pharmaceutical Grade USP L-Glutamine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pharmaceutical Grade USP L-Glutamine Distributors
- 9.2.3 Pharmaceutical Grade USP L-Glutamine Customers
10 Global Pharmaceutical Grade USP L-Glutamine Analyzing Market Dynamics
- 10.1 Pharmaceutical Grade USP L-Glutamine Industry Trends
- 10.2 Pharmaceutical Grade USP L-Glutamine Industry Drivers
- 10.3 Pharmaceutical Grade USP L-Glutamine Industry Opportunities and Challenges
- 10.4 Pharmaceutical Grade USP L-Glutamine Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst